NeurOp, Inc.

United States of America

 
Total IP 9
Total IP Rank # 171,320
IP Activity Score 1.4/5.0    5
IP Activity Rank # 195,044

Patents

Trademarks

4 0
1 0
4 0
0
 
Last Patent 2024 - Glun2b-subunit selective antagon...
First Patent 2008 - Nmda receptor antagonists for ne...

Latest Inventions, Goods, Services

2024 Invention Glun2b-subunit selective antagonists of the n-methyl-d-aspartate receptors with enhanced potency ...
2013 Invention Compounds for the treatment of neurological disorders. In one aspect, the invention relates to NM...
Invention Nmda receptor antagonists for neuroprotection. Provided are compounds, pharmaceutical composition...
2012 Invention Compounds for the treatment of neurological disorders. Provided are compounds, pharmaceutical com...
2010 Invention Compounds for the treatment of neurologic disorders. Provided are compounds, pharmaceutical compo...